Screening for CMR, MetS and related diseases | Screening, identification of risk/abnormal result/diagnosis and implementation of clinical interventions for CMR, MetS and related diseases | Implementation of clinical interventions for CMR, MetS and related diseases | Impact assessment possible? â—Š | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study, Ref | Patient | Profess | Financial | Organisation | Patient | Profess | Financial | Organisation | Patient | Profess | Financial | Organisation | |
MacHaffie [105] | Not an intervention study, questionnaire. | ||||||||||||
Ohlsen [77] | Results of pharmacist input not reported | X | |||||||||||
Runcie [100] | ✓ | ✓ | |||||||||||
Barnes [101] | ✓ | ✓ | ✓ | ||||||||||
Taveira [81] | ✓ | ✓ | ✓ | ✓ | |||||||||
Schneiderhan [89] | ✓ | X | |||||||||||
Gable [90] | ✓ | ✓ | ✓ | X | |||||||||
Lizer [102] | ✓ | ✓ | ✓ | ✓ | |||||||||
Taylor [73] | ✓ | ✓ | X | ||||||||||
DelMonte [88] | ✓ | ✓ | |||||||||||
McCleeary-Monthei [103] | ✓ | ✓ | |||||||||||
Ramanuj [104] | ✓ | ✓ | |||||||||||
Watkins [78] | ✓ | ✓ | ✓ | ✓ | |||||||||
Kjeldsen [92] | ✓ | ✓ | |||||||||||
Cohen [82]a | ✓ | ||||||||||||
Lucca [91] | ✓ | X | |||||||||||
Schneiderhan [84] | ✓ | ✓ | ✓ | ||||||||||
Bozymski [83] | ✓ | ✓ | |||||||||||
Barnes [98] | ✓ | ✓ | ✓ | ||||||||||
Fischler [99] | ✓ | ✓ | |||||||||||
Lee [79] | ✓ | ✓ | |||||||||||
McMorris [74] | ✓ | X | |||||||||||
Porras-Segovia [93] | ✓ | X | |||||||||||
Quirk [75] | Pharmacy designed tool for recording data by other staff, however, exact details unclear | ||||||||||||
Shanker [76] | ✓ | X | |||||||||||
Koffarnus [97] | ✓ | ✓ | ✓ | ||||||||||
Bozymski [87] | ✓ | X | |||||||||||
Sud [86] | ✓ | ✓ | ✓ | ✓ | |||||||||
Sasson [94] | ✓ | ✓ | |||||||||||
Not an intervention study, survey | |||||||||||||
Pena [95] | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||
Health foundation [80] | ✓ | ✓ | ✓ | ✓(for 2 of 4 outcomes measured) | |||||||||
Raynsford [85] | ✓ | X |